These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30165126)

  • 1. Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors.
    Sanford NN; Miao R; Wang H; Goldberg S; Jacobson A; Brunner AM; Cote GM; Yock TI; Ebb DH; Chen YB; Jee KW; Hornicek F; DeLaney TF; Choy E; Chen YL
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):52-61. PubMed ID: 30165126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
    Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second cancers in patients with the Ewing sarcoma family of tumours.
    Navid F; Billups C; Liu T; Krasin MJ; Rodriguez-Galindo C
    Eur J Cancer; 2008 May; 44(7):983-91. PubMed ID: 18353632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
    Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
    Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
    Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
    Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
    Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
    Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment.
    Schwartz B; Benadjaoud MA; Cléro E; Haddy N; El-Fayech C; Guibout C; Teinturier C; Oberlin O; Veres C; Pacquement H; Munzer M; N'guyen TD; Bondiau PY; Berchery D; Laprie A; Hawkins M; Winter D; Lefkopoulos D; Chavaudra J; Rubino C; Diallo I; Bénichou J; de Vathaire F
    Radiat Environ Biophys; 2014 May; 53(2):381-90. PubMed ID: 24419490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases.
    Tabone MD; Terrier P; Pacquement H; Brunat-Mentigny M; Schmitt C; Babin-Boilletot A; Mahmoud HH; Kalifa C
    J Clin Oncol; 1999 Sep; 17(9):2789-95. PubMed ID: 10561354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.
    Foulon S; Brennan B; Gaspar N; Dirksen U; Jeys L; Cassoni A; Claude L; Seddon B; Marec-Berard P; Whelan J; Paulussen M; Streitbuerger A; Oberlin O; Juergens H; Grimer R; Le Deley MC
    Eur J Cancer; 2016 Jul; 61():128-36. PubMed ID: 27176931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
    Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
    La TH; Meyers PA; Wexler LH; Alektiar KM; Healey JH; Laquaglia MP; Boland PJ; Wolden SL
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):544-50. PubMed ID: 16198063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary tumors in bone sarcomas after treatment with chemotherapy.
    Ferrari C; Bohling T; Benassi MS; Ferraro A; Gamberi G; Bacci G; Del prever Ab; Sangiorgi L; Ragazzini P; Sollazzo MR; Balladelli A; Picci P
    Cancer Detect Prev; 1999; 23(5):368-74. PubMed ID: 10468888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.
    Mukherjee S; Reddy CA; Ciezki JP; Abdel-Wahab M; Tiu RV; Copelan E; Advani AA; Saunthararajah Y; Paulic K; Hobson S; Maciejewski JP; Bolwell BJ; Kalaycio M; Dreicer R; Klein EA; Sekeres MA
    J Natl Cancer Inst; 2014 Mar; 106(3):djt462. PubMed ID: 24577815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
    Friedman DN; Chastain K; Chou JF; Moskowitz CS; Adsuar R; Wexler LH; Chou AJ; DeRosa A; Candela J; Magnan H; Pun S; Kahan T; Wolden SL; Meyers PA; Oeffinger KC
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.